Genprex Inc (GNPX)
2.36
-0.07
(-2.88%)
USD |
NASDAQ |
May 10, 12:32
Genprex Cash from Operations (TTM): -24.74M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -24.74M |
September 30, 2023 | -24.32M |
June 30, 2023 | -24.11M |
March 31, 2023 | -20.48M |
December 31, 2022 | -17.62M |
September 30, 2022 | -16.29M |
June 30, 2022 | -14.40M |
March 31, 2022 | -12.89M |
December 31, 2021 | -14.28M |
September 30, 2021 | -14.96M |
June 30, 2021 | -14.34M |
March 31, 2021 | -14.88M |
December 31, 2020 | -13.94M |
September 30, 2020 | -11.76M |
June 30, 2020 | -11.74M |
Date | Value |
---|---|
March 31, 2020 | -9.794M |
December 31, 2019 | -6.919M |
September 30, 2019 | -7.259M |
June 30, 2019 | -6.74M |
March 31, 2019 | -8.285M |
December 31, 2018 | -6.846M |
September 30, 2018 | -4.996M |
June 30, 2018 | -4.165M |
March 31, 2018 | -1.726M |
December 31, 2017 | -2.172M |
September 30, 2017 | -2.809M |
June 30, 2017 | -2.320M |
March 31, 2017 | -1.738M |
December 31, 2016 | -1.248M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-24.74M
Minimum
Dec 2023
-6.74M
Maximum
Jun 2019
-14.81M
Average
-14.34M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
Lifecore Biomedical Inc | -34.46M |
Jaguar Health Inc | -33.24M |
BioXcel Therapeutics Inc | -155.01M |
TFF Pharmaceuticals Inc | -16.04M |
4D Molecular Therapeutics Inc | -75.79M |